Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Images were analyzed with ZEISS ZEN Blue and Fiji softwares
It was originally formulated to treat type II diabetes though the treatment has shown great promise in helping people lose weight, especially when combined with diet and exercise
Retatrutide is an investigational triple incretin receptor agonist under clinical development by Eli Lilly, whilst 5-Amino-1MQ is a research chemical targeting the NNMT enzyme
The most commonly reported adverse effects are gastrointestinal in nature and include nausea, vomiting, diarrhoea, constipation, and abdominal pain
These include infection, bleeding, blood clots, scarring, and nerve damage
Sezer, R
